logo
Plus   Neg
Share
Email

Dr. Reddy's To Sell Migraine Drugs Tosymra, Zembrace To Upsher-Smith Labs

Dr. Reddy's Laboratories Ltd. (RDY,DRREDDY) announced Friday that it has entered into a definitive agreement to sell its neurology branded products to Upsher-Smith Laboratories, LLC.

The company would sell its US and select territory rights for ZEMBRACE SYMTOUCH (sumatriptan injection) 3 mg and TOSYMRA (sumatriptan nasal spray) 10 mg, formerly referred to as "DFN-02". These are commercialized through the company's unit Promius Pharma, LLC.

Under the deal, Dr. Reddy's will receive $70 million as upfront consideration, $40.5 million in near term milestones, as well as additional financial considerations including existing contractual obligation and inventory.

Subsequently, Dr. Reddy's will receive sales based royalties on a quarterly basis.

The closing of the sale is subject to various customary closing conditions including antitrust review under Hart-Scott-Rodino Act.

Anil Namboodiripad, Senior Vice President, Proprietary Products and Head, Promius Pharma, said, "Tosymra and Zembrace were designed and developed with the goal of addressing unmet needs of large but discrete segments of patients suffering from episodic migraine who need options other than their current therapies."

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Chipotle Mexican Grill Inc. is introducing a new protein to its menu, Carne Asada, starting this week. Carne Asada is Chipotle's newest protein addition since it reintroduced chorizo in September 2018. The Mexican food chain said that the new steak option will be available at its restaurants nationwide from Thursday, September 19, 2019. Pizza Hut has partnered with Cheez-It to launch a new item to its menu - the Stuffed Cheez-It Pizza. The pizza chain, a subsidiary of Yum! Brands, said that the new item combines Pizza Hut pizza and the Cheez-It cheese snack. Stuffed Cheez-It Pizza will be available on Pizza Hut menus nationwide for a limited-time. Pizza Hut is the official pizza sponsor of the NFL and NCAA. The U.S. Food and Drug Administration on Tuesday unveiled a new international collaboration for simultaneous review and approval of cancer drugs along with the agency's Australian and Canadian counterparts. The simultaneous approval of cancer therapies by the three regulators is intended to accelerate the process of making these new treatments available to patients around the world.
Follow RTT